Prostate Cancer - Results from #22840

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients - Abstract July 4, 2013

Role of high-field MR in studies of localized prostate cancer - Abstract July 4, 2013

Developments in external beam radiotherapy for prostate cancer - Abstract July 4, 2013

Radical prostatectomy in prostate cancer: Indications and surgical approaches - Abstract July 3, 2013

Single center experience of (18F)-fluorocholine positron emission tomography: Analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma - Abstract July 3, 2013

Genomic region operation kit for flexible processing of deep sequencing data - Abstract July 3, 2013

RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: A prospective study - Abstract July 3, 2013

Results of surgery for high-risk prostate cancer - Abstract July 3, 2013

Risk of mesothelioma following external beam radiotherapy for prostate cancer: A cohort analysis of SEER database - Abstract July 3, 2013

Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden study - Abstract July 3, 2013

Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice - Abstract July 2, 2013

Localized prostate cancer at high risk of progression - Abstract July 2, 2013

Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: Correlation with MRI and imaging fusion - Abstract July 2, 2013

Diagnostic value of utrasound elastography in prostate cancer - Abstract July 2, 2013

Prostatic stromal neoplasms: Differential diagnosis of cystic and solid prostatic and periprostatic masses - Abstract July 2, 2013

TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: Incidence and correlation with ERG immunohistochemistry - Abstract July 2, 2013

Metabolic syndrome as a peculiar target for management of prostate cancer patients - Abstract July 2, 2013

Enzalutamide: A novel anti-androgen with prolonged survival rate in CRPC patients - Abstract July 2, 2013

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone - Abstract July 2, 2013

The outbreak of focal therapy for localized prostate cancer management - Abstract July 2, 2013

Page 1143 of 1437